184 related articles for article (PubMed ID: 33912168)
41. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
Girón-Ortega JA; Márquez-Coello M; Gutiérrez-Saborido D; Arizcorreta A; Cuesta-Sancho S; Girón-González JA
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1863-1871. PubMed ID: 33822285
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
[TBL] [Abstract][Full Text] [Related]
43. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
44. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients.
Laguno M; Martínez-Rebollar M; Casanova M; de Lazzari E; González-Cordón A; Torres B; Inciarte A; Mora L; Ugarte A; Ambrosioni J; Blanco JL; Martínez E; Mallolas J
Clin Microbiol Infect; 2022 Apr; 28(4):610.e1-610.e7. PubMed ID: 34464735
[TBL] [Abstract][Full Text] [Related]
45. Effect of age on the CD4⁺ T-cell impairment in HIV-infected persons without and with cART.
Allers K; Bösel D; Epple HJ; Karcher H; Schmidt W; Kunkel D; Geelhaar-Karsch A; Schinnerling K; Moos V; Schneider T
J Acquir Immune Defic Syndr; 2014 May; 66(1):7-15. PubMed ID: 24378723
[TBL] [Abstract][Full Text] [Related]
46. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.
Körner C; Krämer B; Schulte D; Coenen M; Mauss S; Fätkenheuer G; Oldenburg J; Nattermann J; Rockstroh JK; Spengler U
Clin Sci (Lond); 2009 May; 116(12):861-70. PubMed ID: 19128241
[TBL] [Abstract][Full Text] [Related]
47. The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C.
Li Y; Zeng Y; Zeng G; Li J; Zhang X; Cai Q; Chen Y; Lin CS
J Med Virol; 2019 Feb; 91(2):278-286. PubMed ID: 30171691
[TBL] [Abstract][Full Text] [Related]
48. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
Jiang X; Vouri SM; Diaby V; Lo-Ciganic W; Parker R; Park H
J Manag Care Spec Pharm; 2021 Oct; 27(10):1388-1402. PubMed ID: 34595949
[No Abstract] [Full Text] [Related]
49. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
Moorman JP; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Thayer P; Islam TM; Borthwick T; Yao ZQ
Vaccine; 2011 Apr; 29(17):3169-76. PubMed ID: 21376795
[TBL] [Abstract][Full Text] [Related]
50. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
51. Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.
Ravens S; Hengst J; Schlapphoff V; Deterding K; Dhingra A; Schultze-Florey C; Koenecke C; Cornberg M; Wedemeyer H; Prinz I
Front Immunol; 2018; 9():510. PubMed ID: 29616028
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.
Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Boué F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D;
J Hepatol; 2017 Jul; 67(1):23-31. PubMed ID: 28235612
[TBL] [Abstract][Full Text] [Related]
53. Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection.
Shen T; Chen X; Xu Q; Lu F; Liu S
Arch Virol; 2010 May; 155(5):627-34. PubMed ID: 20204427
[TBL] [Abstract][Full Text] [Related]
54. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J; Heinonen T; Fenwick C; Schrijver IT; Ohmiti K; Moradpour D; Cavassini M; Pantaleo G; Roger T; Calandra T;
Clin Microbiol Infect; 2022 Apr; 28(4):611.e1-611.e7. PubMed ID: 34474121
[TBL] [Abstract][Full Text] [Related]
55. IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia.
Carcelain G; Saint-Mézard P; Altes HK; Tubiana R; Grenot P; Rabian C; de Boer R; Costagliola D; Katlama C; Debré P; Autran B
AIDS; 2003 Apr; 17(6):841-50. PubMed ID: 12660531
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
[TBL] [Abstract][Full Text] [Related]
57. Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.
Hengst J; Falk CS; Schlaphoff V; Deterding K; Manns MP; Cornberg M; Wedemeyer H
J Infect Dis; 2016 Dec; 214(12):1965-1974. PubMed ID: 27683821
[TBL] [Abstract][Full Text] [Related]
58. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
[TBL] [Abstract][Full Text] [Related]
59. Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
Burchill MA; Salomon MP; Golden-Mason L; Wieland A; Maretti-Mira AC; Gale M; Rosen HR
PLoS Pathog; 2021 Aug; 17(8):e1009799. PubMed ID: 34370798
[TBL] [Abstract][Full Text] [Related]
60. The impact of DAA-mediated HCV eradication on CD4
Bandera A; Lorenzini P; Taramasso L; Cozzi-Lepri A; Lapadula G; Mussini C; Saracino A; Ceccherini-Silberstein F; Puoti M; Quiros-Roldan E; Montagnani F; Antinori A; d'Arminio Monforte A; Gori A;
J Viral Hepat; 2021 May; 28(5):779-786. PubMed ID: 33600068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
